BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 37817741)

  • 1. 'Passive' nanoparticles for organ-selective systemic delivery: design, mechanism and perspective.
    Fu L; Zhang Y; Farokhzad RA; Mendes BB; Conde J; Shi J
    Chem Soc Rev; 2023 Oct; 52(21):7579-7601. PubMed ID: 37817741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimuli-Responsive Nanotechnology for RNA Delivery.
    Zhou H; Chen DS; Hu CJ; Hong X; Shi J; Xiao Y
    Adv Sci (Weinh); 2023 Dec; 10(36):e2303597. PubMed ID: 37915127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative review of nanotechnology-based therapeutics for kidney diseases.
    Cheng HT; Ngoc Ta YN; Hsia T; Chen Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1953. PubMed ID: 38500369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Multifunction Smart Nanoparticle based Drug Delivery Systems.
    Fatima H; Naz MY; Shukrullah S; Aslam H; Ullah S; Assiri MA
    Curr Pharm Des; 2022; 28(36):2965-2983. PubMed ID: 35466867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting therapeutics to the glomerulus with nanoparticles.
    Zuckerman JE; Davis ME
    Adv Chronic Kidney Dis; 2013 Nov; 20(6):500-7. PubMed ID: 24206602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
    Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; GrazĂș V; Borm P; Estrada G; Ntziachristos V; Razansky D
    Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycocalyx-Mimicking Nanoparticles with Differential Organ Selectivity for Drug Delivery and Therapy.
    Kim D; Whang CH; Hong J; Prayogo MC; Jung W; Lee S; Shin H; Kim Y; Yu J; Kim MJ; Kim K; Lee HS; Jon S
    Adv Mater; 2024 Jul; 36(27):e2311283. PubMed ID: 38489768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale.
    Dreaden EC; El-Sayed MA
    Acc Chem Res; 2012 Nov; 45(11):1854-65. PubMed ID: 22546051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.
    Puri A; Loomis K; Smith B; Lee JH; Yavlovich A; Heldman E; Blumenthal R
    Crit Rev Ther Drug Carrier Syst; 2009; 26(6):523-80. PubMed ID: 20402623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of Hepatic Macrophages by Therapeutic Nanoparticles.
    Colino CI; Lanao JM; Gutierrez-Millan C
    Front Immunol; 2020; 11():218. PubMed ID: 32194546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering a Nano/Biointerface for Cell and Organ-Selective Drug Delivery.
    Song D; Xu Q
    Langmuir; 2022 Aug; 38(30):9092-9098. PubMed ID: 35852946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Corona-Enabled Systemic Delivery and Targeting of Nanoparticles.
    Chen D; Ganesh S; Wang W; Amiji M
    AAPS J; 2020 Jun; 22(4):83. PubMed ID: 32495039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inorganic-organic Synergy in Nano-hybrids Makes a New Class of Drug with Targeted Delivery: Glutamate Functionalization of Iron Nanoparticles for Potential Bone Marrow Delivery and X-ray Dynamic Therapy.
    Ghosh R; Mondal S; Mukherjee D; Adhikari A; Bhattacharyya M; Pal SK
    Curr Drug Deliv; 2022; 19(10):991-1000. PubMed ID: 35346006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of nanoparticles in cancer: drug delivery and diagnostics.
    Talekar M; Kendall J; Denny W; Garg S
    Anticancer Drugs; 2011 Nov; 22(10):949-62. PubMed ID: 21970851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnological selection.
    Demming A
    Nanotechnology; 2013 Jan; 24(2):020201. PubMed ID: 23242125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organotropic Targeting of Biomimetic Nanoparticles to Treat Lung Disease.
    Holay M; Zhou J; Park JH; Landa I; Ventura CJ; Gao W; Fang RH; Zhang L
    Bioconjug Chem; 2022 Apr; 33(4):586-593. PubMed ID: 35285617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell membrane-camouflaged nanoparticles for drug delivery.
    Luk BT; Zhang L
    J Control Release; 2015 Dec; 220(Pt B):600-7. PubMed ID: 26210440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal-nanotechnology: revolution for efficient therapeutics delivery.
    Kumar A; Pandey AN; Jain SK
    Drug Deliv; 2016; 23(3):681-93. PubMed ID: 24901207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Sub-Micron Particle Based Aerosol Strategies for Efficient Systemic Delivery of Therapeutic Agents.
    Joshi N; Kaur S; Banerjee R
    Curr Pharm Des; 2016; 22(17):2470-80. PubMed ID: 26915832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.